Skip to main content
Premium Trial:

Request an Annual Quote

Jorge Leon, Kevin White, Ariadne Genomics

Premium

People in the News

Jorge Leon has joined the medical advisory board at CytoCore, and his consulting firm, Leomics Associates, will be its consultant, the molecular diagnostics company said last week.

Leon was one of the founders of the molecular diagnostic and applied genomics business at Quest Diagnostics where he served as vice president of applied genomics. He holds a PhD in cellular and molecular biology.


Kevin White will direct the University of Chicago's new Institute for Genomic & Systems Biology beginning in July, according to a university news report.

White comes to Chicago from the Yale University School of Medicine, where he is an associate professor in genetics and ecology and evolutionary biology, as well as director of applied genomics in the Yale Center for RNAi and Therapeutic Chemical Genetics.

White holds a joint BSc-MSc degree in biology from Yale University, and a PhD in developmental biology from Stanford University.

 

New Product Watch

Ariadne Genomics said last week that its PathwayStudio 4.0 pathway analysis software has earned GeneChip-compatible status from Affymetrix. The company has also joined the Affymetrix GeneChip-compatible applications program.

Ariadne is the twentieth software provider to join the Affymetrix GeneChip-compatible applications program since the microarray manufacturer rolled out the program in September 2005. Designated members can market their products to Affymetrix users, as well as take advantage of co-marketing opportunities with the microarray manufacturer (see BAN 9/14/2005).

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.